FORM DEF 14A

Company

Acurx Pharmaceuticals, Inc.

Filed

May 29, 2025

Period of Report

July 17, 2025

Accession Number

0001104659-25-054235

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →